A1 Refereed original research article in a scientific journal

Micronests in Tumor Stroma is a Prognostic Classifier in Nasopharyngeal Carcinoma




AuthorsAlmangush, Alhadi; Ruuskanen, Miia; Hagström, Jaana; Kosma, Veli-Matti; Mäkitie, Antti A.; Leivo, Ilmo

PublisherOvid Technologies (Wolters Kluwer Health)

Publication year2026

Journal: American Journal of Surgical Pathology

ISSN0147-5185

eISSN1532-0979

DOIhttps://doi.org/10.1097/PAS.0000000000002531

Publication's open availability at the time of reportingOpen Access

Publication channel's open availability Partially Open Access publication channel

Web address https://doi.org/10.1097/pas.0000000000002531

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/515914249

Self-archived copy's licenceCC BY

Self-archived copy's versionPublisher`s PDF


Abstract

The assessment of micronests in tumor stroma has been introduced recently for the prognostication of human malignancies. In this multicenter study, we included a total of 110 patients treated for nasopharyngeal carcinoma (NPC) at one of the Finnish University Hospitals. All available hematoxylin and eosin (H&E)-stained slides were scanned. Assessment of micronests in tumor stroma was conducted on scanned HE-stained slides. Presence of micronests in tumor stroma had a significant prognostic value in predicting overall survival in the multivariable analysis with a hazard ratio (HR) of 1.92 (95% CI: 1.14-3.24, P=0.01). Similarly, in the multivariable analysis of disease-specific survival, micronests in tumor stroma had a significant prognostic value with an HR of 1.87 (95% CI: 1.00-3.48, P=0.04). In addition, the presence of micronests in tumor stroma showed a significant association with keratinizing and EBV-negative tumors (P<0.001). In conclusion, the evaluation of micronests in tumor stroma can be used as a prognostic classifier in NPC and they can be assessed in routine H&E-stained sections.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
Finnish Cancer Society, Turku University Hospital Fund, Maritza and Reino Salonen Foundation, Helsinki University Hospital Research Fund


Last updated on 20/03/2026 02:29:03 PM